OREANDA-NEWS. INEOS Barex AG, INEOS Barex USA LLC and MSM Poly LLC announced today they have signed a Memorandum of Understanding for the potential sale of intellectual property (IP) and production support related to the Barex product line.  The non-binding agreement would allow for MSM to purchase all existing IP from INEOS as well as specific physical assets, commercial/operational support and a supply of Barex® resin.

Paul Overment, CEO of INEOS Barex said “This MOU allows both groups to move forward in the process while providing some assurance to current Barex® users that the brand could be made available post the exit of INEOS.”  Barex® resins have been produced by INEOS since 2005 following its acquisition of the Innovene business from BP.  No further details have been released however both parties are working towards completion of the transaction sometime in Q3 of 2016. 

Patrick Mickle, CEO of MSM Poly said, “A core group of pharma packaging and other companies approached us through the consultancy Montesino Associates to seek an alternate, ongoing supply of acrylonitrile methyl acrylate copolymer latex (AMAC) following INEOS’ announcement in late 2014 of their plans to discontinue production of their AMAC formulation marketed under the trade name of Barex®.  We formed for that purpose and are moving rapidly to commercial production.”

INEOS is a global manufacturer of petrochemicals, specialty chemicals and oil products and comprises 18 businesses with over 65 manufacturing sites in 16 countries.  INEOS Barex AG, a Swiss based company is wholly owned by INEOS and is the parent of INEOS Barex USA LLC which currently manages the Barex production site.  INEOS Barex AG announced closure of the Barex business on October 28, 2014 but has continued to operate in an effort to meet guaranteed production volume for contracted customers.  It is expected the production period will conclude in Q3 of 2016 followed by dismantling of the physical assets.  INEOS operates two additional businesses at the Lima, Ohio manufacturing site both of which are unaffected by this closure.